Siponimod is a sphingosine-1-phosphate (S1P) receptor modulator. Siponimod binds with high affinity to S1P receptors 1 and 5. Siponimod blocks the capacity of lymphocytes to egress from lymph nodes, reducing the number of lymphocytes in peripheral blood. The mechanism by which siponimod exerts therapeutic effects in multiple sclerosis is unknown, but may involve reduction of lymphocyte migration into the central nervous system.
Siponimod is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Therapeutic Category : Dyspareunia
CAS Number : 1230487-00-9
Molecular Formula : C29H35F3N2O3
Molecular Weight : 516.6 g/mol
Mesh Size : As per Customer Requirement
Jolly Healthcare Development Status : Wishlist